Broadwood Partners, L.P.
10% owner at STAA; Director at QUESTCOR PHARMACEUTICALS INC; 10% owner at LCTX
- Sold, on record
- $60.8M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jun 15, 2021
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 3
- Filed as an executive or holder
Companies
- STAASTAAR SURGICAL CO10% owner
- QUESTCOR PHARMACEUTICALS INCDirector
- LCTXLineage Cell Therapeutics, Inc.10% owner
Sales by reason
0
Routine
4
Plan not stated
0
No plan
0
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- STAA325,828 shares
- QUESTCOR PHARMACEUTICALS INC282,000 shares
- LCTX267,365 shares
Shares sold, every Form 4 sale on record.
Timeline
- Jun 15, 2021Plan not stated
Sold 0.7% of their holdings
$8.8M59,550 shares at $147.57
- Jun 1, 2021Plan not stated
Sold 2.9% of their holdings
$39.1M266,278 shares at $146.71
- Jun 14, 2013Plan not stated
Sold 7.9% of their holdings
$12.9M282,000 shares at $45.62
- Dec 21, 2007Plan not stated
Sold 13.9% of their holdings
$80k267,365 shares at $0.30
4 of 4
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | Nov 19, 2026 | LCTX | Director, 10% owner | Bought | 1M | $0.77 | $771k | 50.6M | SEC |
| Nov 17, 2026 | Nov 19, 2026 | IMDX | 10% owner | Bought | 3.4M | $1.75 | $6M | 16.1M | SEC |
| Apr 27, 2026 | Apr 27, 2026 | IMDX | 10% owner | Bought | 570,184 | $3.56 | $2M | 12.7M | SEC |
| Apr 7, 2025 | Apr 7, 2025 | STAA | 10% owner | Bought | 845,220 | $16.12 | $13.6M | 13.3M | SEC |
| Apr 2, 2025 | Apr 2, 2025 | STAA | 10% owner | Bought | 53,969 | $17.44 | $941k | 12.5M | SEC |
| Feb 6, 2025 | Feb 10, 2025 | IMDX | 10% owner | Bought | 5.2M | $2.05 | $10.6M | 11.4M | SEC |
| May 9, 2024 | May 13, 2024 | STAA | 10% owner | Bought | 1 | $42.56 | $43 | 10.8M | SEC |
| Apr 15, 2024 | Apr 15, 2024 | IMDX | 10% owner | OtherSeries A Convertible Preferred Stock | 2,941 | 0 | SEC | ||
| Apr 11, 2024 | Apr 15, 2024 | IMDX | 10% owner | Bought | 2.4M | $2.92 | $7.1M | 4.9M | SEC |
| Feb 6, 2024 | Feb 8, 2024 | LCTX | Director, 10% owner | Bought | 6.7M | $1.04 | $7M | 41.7M | SEC |
| Jan 5, 2024 | Jan 5, 2024 | STAA | 10% owner | Bought | 226,553 | $28.61 | $6.5M | 10.8M | SEC |
| Apr 3, 2023 | Apr 5, 2023 | IMDX | 10% owner | Bought | 26.8M | $0.30 | $8M | 50.2M | SEC |
| Dec 29, 2022 | Dec 29, 2022 | STAA | 10% owner | Bought | 191,075 | $47.43 | $9.1M | 8.8M | SEC |
| Apr 14, 2022 | Apr 15, 2022 | IMDX | 10% owner | Bought | 6M | $1.33 | $8M | 23.4M | SEC |
| Apr 14, 2022 | Apr 15, 2022 | IMDX | 10% owner | AwardedSeries A Convertible Preferred Stock | 6M | 6M | SEC | ||
| Oct 1, 2021 | Oct 1, 2021 | STAA | 10% owner | Other | 71,577 | 8.6M | SEC | ||
| Sep 23, 2021 | Sep 24, 2021 | IMDX | 10% owner | Exercised or settledWarrant to Purchase Common Stock | 573,461 | 0 | SEC | ||
| Sep 23, 2021 | Sep 24, 2021 | IMDX | 10% owner | Exercised options | 573,461 | $3.15 | $1.8M | 17.3M | SEC |
| Sep 23, 2021 | Sep 24, 2021 | IMDX | 10% owner | Returned to the companyWarrant to Purchase Common Stock | 573,461 | 0 | SEC | ||
| Sep 23, 2021 | Sep 24, 2021 | IMDX | 10% owner | AwardedWarrant to Purchase Common Stock | 573,461 | 573,461 | SEC | ||
| Jun 15, 2021 | Jun 15, 2021 | STAA | 10% owner | Sold | 59,550 | $147.57 | $8.8M | 9M | SEC |
| Jun 1, 2021 | Jun 1, 2021 | STAA | 10% owner | Sold | 266,278 | $146.71 | $39.1M | 9.1M | SEC |
| Sep 11, 2019 | Sep 13, 2019 | IMDX | 10% owner | Bought | 2M | $1.66 | $3.3M | 11.1M | SEC |
| Jul 2, 2019 | Jul 2, 2019 | IMDX | 10% owner | Bought | 1M | $2.00 | $2M | 9.1M | SEC |
| Oct 1, 2018 | Oct 3, 2018 | STAA | 10% owner | Other | 114,549 | 10.7M | SEC | ||
| Oct 16, 2017 | Oct 18, 2017 | Asterias Biotherapeutics, Inc. | Other | Bought | 1.6M | $2.60 | $4.1M | 5.3M | SEC |
| Sep 11, 2017 | Sep 13, 2017 | COMARCO INC | 10% owner | BoughtSeries A Contingent Convertible Preferred Stock | 5M | 5M | SEC | ||
| Sep 11, 2017 | Sep 13, 2017 | COMARCO INC | 10% owner | OtherRights to be Issued Warrants | 18M | 18M | SEC | ||
| Jul 31, 2017 | Aug 2, 2017 | LCTX | Director, 10% owner | Bought | 150,000 | $2.80 | $420k | 27.3M | SEC |
| Feb 15, 2017 | Feb 17, 2017 | LCTX | Director, 10% owner | Bought | 2.2M | $2.70 | $6M | 27.1M | SEC |
| Jun 21, 2016 | Jun 23, 2016 | LCTX | Director, 10% owner | Bought | 2.7M | $2.39 | $6.5M | 24.9M | SEC |
| Feb 3, 2016 | Feb 4, 2016 | STAA | 10% owner | Bought | 121,599 | $6.41 | $779k | 9.8M | SEC |
| Feb 1, 2016 | Feb 1, 2016 | STAA | 10% owner | Bought | 65,983 | $6.48 | $428k | 9.7M | SEC |
| Jan 27, 2016 | Jan 27, 2016 | STAA | 10% owner | Bought | 239,013 | $6.63 | $1.6M | 9.6M | SEC |
| Jan 20, 2016 | Jan 22, 2016 | LCTX | Director, 10% owner | Bought | 300,000 | $2.35 | $705k | 22.2M | SEC |
| Jan 20, 2016 | Jan 21, 2016 | STAA | 10% owner | Bought | 72,858 | $6.75 | $492k | 9.3M | SEC |
| Jan 4, 2016 | Jan 4, 2016 | STAA | 10% owner | Bought | 165,461 | $7.11 | $1.2M | 8.8M | SEC |
| Oct 2, 2015 | Oct 6, 2015 | LCTX | Director, 10% owner | Other | 1.6M | $3.19 | $5.1M | 21.9M | SEC |
| Aug 25, 2015 | Aug 25, 2015 | STAA | 10% owner | Bought | 188,881 | $7.17 | $1.4M | 8.3M | SEC |
| May 21, 2015 | May 26, 2015 | Asterias Biotherapeutics, Inc. | Other | Exercised or settledWarrant to Purchase Series A Common Stock | 1M | 0 | SEC | ||
| May 21, 2015 | May 26, 2015 | Asterias Biotherapeutics, Inc. | Other | Exercised options | 1M | $2.34 | $2.3M | 1.6M | SEC |
| Nov 10, 2014 | Nov 12, 2014 | STAA | 10% owner | Bought | 500 | $8.79 | $4k | 7.2M | SEC |
| Oct 8, 2014 | Oct 8, 2014 | LCTX | Director, 10% owner | Other | 4M | $3.12 | $12.6M | 17.8M | SEC |
| Aug 14, 2014 | Aug 18, 2014 | QUESTCOR PHARMACEUTICALS INC | Director | Other | 1.8M | 0 | SEC | ||
| Aug 14, 2014 | Aug 18, 2014 | QUESTCOR PHARMACEUTICALS INC | Director | Returned to the companyStock Option (right to buy) | 251,917 | 0 | SEC | ||
| Aug 14, 2014 | Aug 18, 2014 | QUESTCOR PHARMACEUTICALS INC | Director | Returned to the company | 11,683 | 0 | SEC | ||
| Jul 22, 2014 | Jul 24, 2014 | LCTX | Director, 10% owner | Bought | 370,000 | $2.65 | $981k | 13.8M | SEC |
| Jun 16, 2014 | Jun 18, 2014 | Asterias Biotherapeutics, Inc. | Other | OtherWarrant to Purchase Series B Common Stock | 1M | 1M | SEC | ||
| Feb 25, 2014 | Feb 27, 2014 | LCTX | Director, 10% owner | Bought | 500,000 | $3.74 | $1.9M | 9.8M | SEC |
| Dec 12, 2013 | Dec 16, 2013 | STAA | 10% owner | Exercised or settledCommon Stock Warrants | 700,000 | 0 | SEC |
Page 1
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2021 | Jun 15, 2021 | STAA | 10% owner | Form 4 sale | 59,550 | $8.8M | 0.7% | Plan not stated | SEC |
| Jun 1, 2021 | Jun 1, 2021 | STAA | 10% owner | Form 4 sale | 266,278 | $39.1M | 2.9% | Plan not stated | SEC |
| Jun 14, 2013 | Jun 17, 2013 | QUESTCOR PHARMACEUTICALS INC | Director | Form 4 sale | 282,000 | $12.9M | 7.9% | Plan not stated | SEC |
| Dec 21, 2007 | Dec 27, 2007 | LCTX | 10% owner | Form 4 sale | 267,365 | $80k | 13.9% | Plan not stated | SEC |